Home›People›Preston Campbell
Preston Campbell

Preston Campbell

Director at Halia Therapeutics.

Director
Updated Nov 9, 2026·Latest SEC filing Aug 31, 2026·Suggest an edit

About Preston Campbell

Preston Campbell is a director at Halia Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Preston Campbell in the role, so the role may have started earlier or lasted longer.

Halia Therapeutics, Inc.
Director
2026 · Lehi, UT
Develops investigational drugs for people with inflammatory and neurological diseases.

Key Colleagues at Startups

The people Preston Campbell works with at each company, as listed on that company's latest Form D.

Halia Therapeutics, Inc. · Form D, Aug 31, 2026
MB
Gary Sabin
Gary Sabin
Executive Chairman
Jeffrey Burton
Jeffrey Burton
Chief Financial Officer
David Bearss
David Bearss
Chief Executive Officer and director
John Kauwe
John Kauwe
Co-Founder and director

Sources

  1. SECHalia Therapeutics, Inc. Form D, filed Aug 31, 2026